1. Home
  2. DORM vs KNSA Comparison

DORM vs KNSA Comparison

Compare DORM & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

HOLD

Current Price

$109.36

Market Cap

4.0B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$46.96

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DORM
KNSA
Founded
1978
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
DORM
KNSA
Price
$109.36
$46.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$160.25
$55.29
AVG Volume (30 Days)
231.5K
565.9K
Earning Date
05-04-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
8.14
225.00
EPS
6.64
0.75
Revenue
$2,130,319,000.00
$677,564,000.00
Revenue This Year
$9.70
$38.01
Revenue Next Year
$4.92
$17.42
P/E Ratio
$16.55
$63.27
Revenue Growth
6.03
60.09
52 Week Low
$98.45
$19.42
52 Week High
$166.88
$50.03

Technical Indicators

Market Signals
Indicator
DORM
KNSA
Relative Strength Index (RSI) 53.67 51.17
Support Level $98.45 $39.96
Resistance Level $109.88 $48.14
Average True Range (ATR) 3.25 1.83
MACD 1.38 -0.03
Stochastic Oscillator 89.72 45.20

Price Performance

Historical Comparison
DORM
KNSA

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: